Case Study

Fortune 1000 Pharmaceutical Company Tightens Security with Fidelis Deception*

Fortune 1000 Pharmaceutical Company Tightens Security with Fidelis Deception*

Pages 2 Pages

This Fortune 1000 pharmaceutical company develops, manufactures, and commercializes therapies for various diseases and underserved conditions. With a Global Innovation and R&D Center in North America, it operates advanced manufacturing facilities and distributes products in over 100 countries. The company employs more than 15,000 people worldwide. Its main challenge is securing sensitive intellectual property while complying with FDA and DEA regulations. Information security also covers internal communication channels and data shared with a broad network of suppliers and partners, ensuring regulatory compliance and protection of critical assets.

Join for free to read